Post Tagged with: "NASDAQ:ARNA"

5 Active Stocks: Xilinx Inc. (NASDAQ:XLNX), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Atossa Genetics (NASDAQ:ATOS), NeuStar (NYSE:NSR), Arena Pharmaceuticals (NASDAQ:ARNA)

March 10, 2015 at 1:37 pm 0 comments

Xilinx Inc. (NASDAQ:XLNX) on 5 March 2015, announced immediate availability of the winter 2015 edition of its award-winning user magazine, Xcell Journal. The cover story for the 90th issue of Xcell Journal takes a system-level look at Xilinx’s newly unveiledRead More

Investors Are Eying: Tesla Motors Inc (NASDAQ:TSLA), Capnia (NASDAQ:CAPN), On Track Innovations (NASDAQ:OTIV), Heat Biologics (NASDAQ:HTBX), Arena Pharmaceuticals (NASDAQ:ARNA)

March 9, 2015 at 1:55 pm 0 comments

Tesla Motors Inc. (NASDAQ:TSLA) said it’s cutting jobs in China after a local newspaper reported the company will reduce staff by 30 percent. Tesla will eliminate some positions as it makes structural changes to its business in China, Gary Tao,Read More

• Stocks News Alert: La Jolla Pharmaceutical Co. (NASDAQ:LJPC), Alteva (NYSEMKT:ALTV), American Residential Properties (NYSE:ARPI), Arena Pharmaceuticals (NASDAQ:ARNA), Limelight Networks (NASDAQ:LLNW)

March 9, 2015 at 1:32 pm 0 comments

Equities researchers at Chardan Capital initiated coverage on shares of La Jolla Pharmaceutical Co (NASDAQ:LJPC) in a research report issued on Monday. The firm set a “buy” rating and a $54.00 price target on the stock. On Friday shares ofRead More

Why Trader’s Are Watching: Nokia Corporation (ADR) (NYSE:NOK), Glori Energy (NASDAQ:GLRI), Neonode (NASDAQ:NEON), Galena Biopharma (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA)

March 9, 2015 at 10:26 am 0 comments

Fresh reports have emerged claiming that Nokia Corporation (ADR) (NYSE:NOK) is developing a new smartphone called the Nokia 1100 that is powered by Android 5.0 Lollipop. Following its recent acquisition by Microsoft, the “new” Nokia has been expected to comeRead More

Active Movers: Second Sight Medical Products (NASDAQ:EYES), eBay Inc. (NASDAQ:EBAY), Aeterna Zentaris Inc. (NASDAQ:AEZS), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Arena Pharmaceuticals (NASDAQ:ARNA)

March 6, 2015 at 3:02 pm 0 comments

Second Sight Medical Products, Inc. (Nasdaq: EYES) announced that two newly approved centers, located in Camposampiero and Florence, have successfully completed their first commercial implants of the Argus II Retinal Prosthesis System (“Argus II”) in patients with outer retinal degeneration.Read More

Top Movers: Active Power Inc. (NASDAQ:ACPW), Arena Pharmaceuticals (NASDAQ:ARNA), SUPERVALU Inc. (NYSE:SVU), (NASDAQ:WIX), Clovis Oncology (NASDAQ:CLVS)

March 6, 2015 at 1:32 pm 0 comments

Active Power, Inc. (NASDAQ: ACPW), has been invited to present at the 27th Annual ROTH Conference being held March 8-11, 2015, at the Ritz Carlton in Dana Point, Calif. On Thursday shares of Active Power Inc. (NASDAQ:ACPW) closed at $2.49.Read More

Big Movers in Focus: General Electric Company (NYSE:GE), Tesla Motors Inc (NASDAQ:TSLA), Teekay Tankers (NYSE:TNK), Arena Pharmaceuticals (NASDAQ:ARNA), Baidu Inc (NASDAQ:BIDU)

March 5, 2015 at 3:18 pm 0 comments

Two General Electric Company (NYSE:GE)’s divisions led by Cleveland State University graduates have committed $500,000 towards scholarships for CSU students pursuing science, technology, engineering or math degrees. GE Lighting and GE Transportation established the GE Scholars program, which will awardRead More

Watch 5 Stocks: Arena Pharmaceuticals (NASDAQ:ARNA), The Dow Chemical Company (NYSE:DOW), BP p.l.c. (NYSE:BP), Beacon Roofing Supply (NASDAQ:BECN), Ariad Pharmaceuticals (NASDAQ:ARIA)

March 5, 2015 at 3:12 pm 0 comments

On March 2, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported a fourth-quarter 2014 loss of 15 cents per share, wider than the Zacks Consensus Estimate of a loss of 13 cents and the year-ago loss of 11 cents. Total revenues increased 41.1%Read More

What’s Hot: Arena Pharmaceuticals (NASDAQ:ARNA), Merck & Co. Inc. (NYSE:MRK), Daegis Inc. (NASDAQ:DAEG), DIRECTV (NASDAQ:DTV), Citigroup Inc. (NYSE:C)

March 5, 2015 at 3:12 pm 0 comments

On March 2, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported a loss for the fourth quarter that widened from last year, despite a revenue surge, reflecting higher research and development expenses. Total revenues for the quarter surged to $9.19 million from $6.52Read More

Traders Are Gambling on: Arena Pharmaceuticals (NASDAQ:ARNA), Weibo Corporation (NASDAQ:WB), Francesca’s Holdings Corporation (NASDAQ:FRAN), Clean Diesel Technologies Inc. (NASDAQ:CDTI), AxoGen (NASDAQ:AXGN)

March 5, 2015 at 2:50 pm 0 comments

On 2 March, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported Revenues totaled $9.2 million, including $3.8 million in net product sales of BELVIQ, of which $3.2 million represented 31.5% of Eisai’s net product sales and $0.6 million related to redemptions of theRead More